Shares of the BELLUS Health Inc. (BLU) stock were soaring in the current market trading session on December 13, 2021. BLU stock price saw a push of 61% to reach $9.06 a share at the time of this writing. The stock was declining in the previous trade and went down by 1.23% at closing. Let’s […]
BELLUS Health Inc. (BLU) stock is soaring in the current market: Here’s Why Read More »
Shares of the ARNA stock skyrocketed in the current market today on December 13, 2021. ARNA stock price saw a surge of 86.20% to reach $43.05 a share at the time of this writing. The stock was gloomy in the previous trading session and went low by 5.33% at closing. Let’s deep dive to explore
Arena Pharmaceuticals, Inc. (ARNA) skyrocketed in the current market: Why is it so? Read More »
Shares of the bluebird bio, Inc. (BLUE) stock were popping high in the premarket today on December 13, 2021. The BLUE stock price saw a push of 15.96% to reach $10.39 a share at the time of this writing. The stock was gloomy in the previous trade and went low by 4.48% at closing. Let’s
bluebird bio, Inc. (BLUE) stock is Popping high in premarket: Here’s Why Read More »
Oasis Network peaked towards the end of November – establishing a new all-time high at $0.46. Market corrections followed suit after the ATH was recorded and the cryptocurrency was expected to be moving downhill for a while; however, the downtrend was soon reversed amidst strong fundamentals and recent developments. During the past twenty-four hours, ROSE
Oasis Network – What’s been up in the ecosystem? Read More »
1inch Network reached to its all-time high of $7.5 during May as the bull run of 2021 peaked. However, the cryptocurrency fell brutally as the market began to correct itself. The bulls, once again, picked up for the cryptocurrency in November and it skirted close to the ATH; however, the token delved into market corrections,
1inch Network – Is it a good bet? Read More »
SushiSwap peaked during the beginning of 2021 in March amidst the bull run after establishing its new all-time high but subsequent bullish momentum fell short for the cryptocurrency as it could not reach its ATH. The token has been consolidating since October and began a downtrend as November began. Sushi token has been declining steadily
SushiSwap – Upcoming developments to watch out for Read More »
As December began, Syscoin started gaining bullish pressures and skirted close to its all-time high of $0.98. The 52-week high was established at a price level of $0.89. Subsequently, the market began to correct itself as the cryptocurrency became highly volatile. At the time of writing, SYS token stands at a price level of $0.71.
Syscoin – Solving the blockchain trilemma Read More »
Following the announcement of a $2.0M public offering, Avenue Therapeutics Inc. (ATXI) was down by 15.9% at the last check, in the premarket today. In the previous session, the stock traded in the green, closing the session at $1.32 with a 5.60% increase. At the time of writing, ATXI stock was in the red at
$2.0M Public Offering: Avenue Therapeutics Inc. (ATXI) in the Red Pre-market Read More »
Checkpoint Therapeutics Inc. (CKPT) stock was up by 6.85% at $3.12 in the after-hours at 20.36K shares on December 10. The stock has been under market corrections since it gained well on the company’s new trial announcement. CKPT had announced the initiation of its product’s trial for lung cancer patients on December 08. In the
Checkpoint Therapeutics Inc. (CKPT) Stock Rebounds in the After Hours Read More »
TherapeuticsMD Inc. (TXMD) stock extended losses by 5.41% aftermarket when the company announced FDA’s response. The FDA declined TXMD’s Annovera’s previously submitted sNDA. During regular trading, the stock lost 3.30% at a volume of 4.71 million, closing the session at $0.4510. Following the announcement, the stock plunged further down to reach $0.4266 in the after-hours
FDA’s Response: TherapeuticsMD Inc. (TXMD) Plummets Further Aftermarket Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.